Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Combined With Pregabalin for Chronic Postsurgical Pain After Craniotomy
NCT05160493Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic postsurgical pain (CPSP) comparing S-ketamine + Pregabalin with Placebo (2 arms). Primary endpoint: Proportion of craniotomy patients with NRS score greater than one 3 months after surgery. Started Dec 2021; status: completed.
02
Drugs
esketaminepregabalin
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT05160493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05160493.